A
ADXN
Addex Therapeutics Ltd American Depositary Shares
$2.65
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Addex Therapeutics Ltd American Depositary Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$0.06
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Nov 9
Posts
No posts about ADXN yet.
About Addex Therapeutics Ltd American Depositary Shares
Addex Therapeutics is a small Swiss biotech company that develops experimental drugs for brain and nervous system conditions. It has no approved products on the market. It earns small amounts of revenue from research partnerships and licensing deals, and it relies mostly on raising money from investors to pay for its research. Its shares trade in the US as American Depositary Shares, which are certificates that represent shares of the Swiss company.